Search

Flagship Pioneering Innovations V Inc. has been issued a patent for compositions and methods to control insects that carry vector-borne diseases, such as malaria. The patent involves delivering antimicrobial peptides to decrease the fitness of insect vectors for human pathogens. The compositions can be formulated in various ways and target microorganisms in vectors for human pathogens. [Extracted from the article]

A recent study conducted at Chosun University in South Korea focused on the development of novel antimicrobial agents to combat multidrug-resistant pathogens. Researchers designed and synthesized tryptophan-substituted analogs of the antimicrobial peptide BP100, which showed enhanced antibacterial, anti-inflammatory, and antibiofilm activities. These analogs demonstrated improved efficacy in suppressing pro-inflammatory cytokine release and eradicating biofilms of multidrug-resistant bacteria. The study suggests that these analogs could be promising candidates for treating bacterial infections resistant to traditional antibiotics. [Extracted from the article]

Researchers at Capital Medical University in Beijing, China have developed a novel biosensor for the rapid and accurate detection of healthcare-associated infection (HAI)-related bacteria. The biosensor utilizes an antimicrobial peptide called cecropin 1 (CP1) immobilized on the surface of Fe3O4@Au nanoparticles to capture Pseudomonas aeruginosa and Escherichia coli O157:H7 simultaneously. The biosensor demonstrated excellent capturing ability, magnetic enrichment function, and antibacterial activity. It also exhibited high sensitivity and specificity when applied to urine samples. The researchers believe that this biosensor has great potential for detecting multiple bacteria after infection and monitoring therapeutic efficacy. [Extracted from the article]

A recent study conducted by researchers from Maria Curie-Sklodowska University focused on the modification of surgical biomaterials with antimicrobial cationic peptides. The researchers found that the modified biomaterials inhibited the growth of certain bacterial strains and stimulated the immune response. The study also examined the effects of different forms of the peptides on cell viability and proliferation. The findings suggest that these modified biomaterials have potential applications in promoting antibacterial immune responses. [Extracted from the article]

A recent study conducted by researchers at Ghent University in Belgium has explored the potential of engineered phage lysins as antimicrobial compounds targeting Gram-negative bacteria. The study focused on lysin 1D10, which demonstrated a distinct mode of action by causing local cell wall bulging at the septum rather than cell-wide lysis. The researchers also found that lysin 1D10, along with its component cecropin A, showed activity against Acinetobacter baumannii without being cytotoxic to human keratinocytes. The study provides valuable insights for future research in the development of engineered lysins as alternatives to antibiotics. [Extracted from the article]

Keywords: Antimicrobial Cationic Peptides; Cecropins; Genetics; Membrane Proteins EN Antimicrobial Cationic Peptides Cecropins Genetics Membrane Proteins 1651 1651 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Genomics & Genetics Weekly -- Investigators publish new report on antimicrobial cationic peptides. Antimicrobial Cationic Peptides, Genetics, Membrane Proteins, Cecropins Keywords for this news article include: China Agricultural University, Beijing, People's Republic of China, Asia, Antimicrobial Cationic Peptides, Genetics, Cecropins, Membrane Proteins. [Extracted from the article]

Antimicrobial peptides (AMPs) have recently attracted attention as a novel therapeutic strategy for the treatment of various cancers, targeting tumor cells with less toxicity to normal tissues. Keywords: Antibiotics; Antimicrobial Cationic Peptides; Antimicrobials; Cancer; Cecropins; Colon Cancer; Colorectal Research; Drugs and Therapies; Gastroenterology; Health and Medicine; Membrane Proteins; Oncology; Pharmaceuticals EN Antibiotics Antimicrobial Cationic Peptides Antimicrobials Cancer Cecropins Colon Cancer Colorectal Research Drugs and Therapies Gastroenterology Health and Medicine Membrane Proteins Oncology Pharmaceuticals 342 342 1 07/31/23 20230804 NES 230804 2023 AUG 1 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on colon cancer is the subject of a new report. [Extracted from the article]

For more information on this research see: Synergistic effect of ultrasound and antimicrobial solutions of cecropin P1 in the deactivation of Escherichia coli O157:H7 using a cylindrical ultrasonic system. Keywords: Antimicrobial Cationic Peptides; Cecropins; Drugs and Therapies; Enterobacteriaceae; Escherichia coli; Escherichia coli O157:H7; Foodborne Diseases and Conditions; Gram-Negative Bacteria; Health and Medicine; Membrane Proteins; Proteobacteria EN Antimicrobial Cationic Peptides Cecropins Drugs and Therapies Enterobacteriaceae Escherichia coli Escherichia coli O157:H7 Foodborne Diseases and Conditions Gram-Negative Bacteria Health and Medicine Membrane Proteins Proteobacteria 1864 1864 1 07/24/23 20230725 NES 230725 2023 JUL 28 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- New research on Escherichia coli O157:H7 is the subject of a new report. [Extracted from the article]

Antibiotics, Antimicrobial Cationic Peptides, Antimicrobials, Colistin, Colistin Therapy, Drugs and Therapies, Enterobacteriaceae, Escherichia coli, Gram-Negative Bacteria, Health and Medicine, Membrane Proteins, Pharmaceuticals, Polymyxins, Pore Forming Cytotoxic Proteins, Proteobacteria, Cecropins Keywords: Antibiotics; Antimicrobial Cationic Peptides; Antimicrobials; Cecropins; Colistin; Colistin Therapy; Drugs and Therapies; Enterobacteriaceae; Escherichia coli; Gram-Negative Bacteria; Health and Medicine; Membrane Proteins; Pharmaceuticals; Polymyxins; Pore Forming Cytotoxic Proteins; Proteobacteria EN Antibiotics Antimicrobial Cationic Peptides Antimicrobials Cecropins Colistin Colistin Therapy Drugs and Therapies Enterobacteriaceae Escherichia coli Gram-Negative Bacteria Health and Medicine Membrane Proteins Pharmaceuticals Polymyxins Pore Forming Cytotoxic Proteins Proteobacteria 744 744 1 07/10/23 20230714 NES 230714 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Researchers detail new data in Escherichia coli. [Extracted from the article]